期刊文献+

口服聚酯聚醚疫苗蛋白微球的制备研究 被引量:11

PREPARATION OF POLY DL LACTIDE b POLYETHYLENE GLYCOL MICROSPHERES ENCAPSULATING HUMAN SERUM ALBUMIN
下载PDF
导出
摘要 采用本体聚合法合成不同聚醚含量的聚酯聚醚嵌段共聚物聚DL乳酸聚乙二醇(PolyDLlactidebpolyethyleneglycol,PELA).PELA及PLA包裹人血清白蛋白(HSA)微球采用溶剂挥发法双乳液体系(W1/O/W2)制备.微球球形规整,粒径集中在05~50μm.用CBB法检测微球中蛋白含量,蛋白包裹量达25%,包裹效率近80%.从双乳液体系中界面张力角度考察了聚合物囊材的性质、稳定剂的种类及W1/O的稳定性等对微球粒径及蛋白包裹量的影响.微球体外释放结果表明PELA蛋白微球的突释现象不明显,释放速度较为恒定. The purpose of this article is to explore the methods preparing biodegradable microspheres delivery system of vaccines by oral targeting administration.A series of polymers of DL lactide and polyethylene glycol(PEG) with different contents of PEG were synthesized and the microspheres containing human serum albumin(HSA) were prepared by a solvent evaporation method using a W/O/W emulsion.The scanning electron micrograph of microspheres showed a smooth and spheric surface.The size of microspheres could be controlled between 0 5~10μm,which is essential for microspheres to reach the target sites.The amount of protein in microspheres was 2 5% determined by CBB method and the entrapemnt ratio achieved approximately 80%.It was concluded that the properties of polymers,stabilizer system and solvent in oil phase had great effect on the formation of microspheres,particle size and the protein entrapment ratio.In vitro studies indicated that protein carrying microspheres of PLA had a larger burst effect than that of PELA 10.
出处 《高分子学报》 SCIE CAS CSCD 北大核心 1999年第2期156-161,共6页 Acta Polymerica Sinica
基金 国家自然科学基金
关键词 疫苗蛋白 缓释制剂 共聚物 人血清白蛋白 微球 Poly DL lactide polyethylene glycol(PELA),Human serum albumin,Microspheres,Oral administration
  • 相关文献

参考文献5

二级参考文献2

  • 1Zhu K J,J Appl Polym Sci,1990年,39卷,1页
  • 2邓先模,J Polym Sci Polym Lett Ed,1990年,28卷,411页

共引文献31

同被引文献189

引证文献11

二级引证文献175

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部